Publications by authors named "Subroto Acharjee"

Claim this Profile
O
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
Subroto Acharjee, Koon K Teo, Alice K Jacobs, Pamela M Hartigan, Kulpreet Barn

Am Heart J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on ranolazine in the management of angina.
J Nicolás Codolosa, Subroto Acharjee, Vincent M Figueredo

Vasc Health Risk Manag· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status.
Subroto Acharjee, Jin-Rong Zhou, Tarec K Elajami, Francine K Welty

Metabolism· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
Subroto Acharjee, William E Boden, Pamela M Hartigan, Koon K Teo, David J Maron

J Am Coll Cardiol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
Subroto Acharjee, Matthew T Roe, Ezra A Amsterdam, DaJuanicia N Holmes, William E Boden

Am J Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism.
Subroto Acharjee, Christopher P Cannon

Crit Pathw Cardiol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidence.
Subroto Acharjee, Christopher P Cannon

Crit Pathw Cardiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers.
Subroto Acharjee, Christopher P Cannon

Crit Pathw Cardiol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial).
Subroto Acharjee, Jie Qin, Sabina A Murphy, Carolyn McCabe, Christopher P Cannon

Am J Cardiol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous coronary intervention. Cardiovascular outcomes and long-term clopidogrel use after PCI in patients with diabetes.
Christopher P Cannon, Subroto Acharjee

Rev Cardiovasc Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome.
Yuheng Ruan, Jonathan S Bridges, Kapil Kumar, Jonelle A Raphael, Subroto Acharjee

Clin Rheumatol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute coronary syndrome. Cardiovascular events after clopidogrel discontinuation.
Christopher P Cannon, Subroto Acharjee

Rev Cardiovasc Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin and cardiovascular risk in the elderly--patient considerations.
Subroto Acharjee, Francine K Welty

Clin Interv Aging· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis